GNOM.L vs. BTEK.L
GNOM.L (Global X Genomics & Biotechnology UCITS ETF) and BTEK.L (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds - GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF while BTEK.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 3 years, GNOM.L returned 4.58%/yr vs 17.58%/yr for BTEK.L. A 0.80 correlation means they provide meaningful diversification when combined. GNOM.L charges 0.50%/yr vs 0.35%/yr for BTEK.L.
Performance
GNOM.L vs. BTEK.L - Performance Comparison
Loading charts...
Different Trading Currencies
GNOM.L is traded in USD, while BTEK.L is traded in GBP. To make them comparable, the BTEK.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GNOM.L achieves a 22.10% return, which is significantly higher than BTEK.L's 15.09% return.
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
BTEK.L
- 1D
- 1.00%
- 1M
- 9.60%
- 6M
- 13.21%
- YTD
- 15.09%
- 1Y
- 50.03%
- 3Y*
- 17.58%
- 5Y*
- 5.91%
- 10Y*
- —
GNOM.L vs. BTEK.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 15.09% | 32.98% | -1.86% | 5.59% | -12.08% | -5.16% |
Correlation
The correlation between GNOM.L and BTEK.L is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.80 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.80 |
The correlation between GNOM.L and BTEK.L has been stable across timeframes, ranging from 0.79 to 0.80 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM.L vs. BTEK.L — Risk / Return Rank
GNOM.L
BTEK.L
GNOM.L vs. BTEK.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOM.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM.L | BTEK.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.36 | ||
| Sortino ratioReturn per unit of downside risk | -0.44 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.40 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 6.38 | -3.03 |
| Martin ratioReturn relative to average drawdown | 9.16 | 18.62 | -9.46 |
Loading charts...
Drawdowns
GNOM.L vs. BTEK.L - Drawdown Comparison
The maximum GNOM.L drawdown since its inception was -69.32%, which is greater than BTEK.L's maximum drawdown of -38.25%. Use the drawdown chart below to compare losses from any high point for GNOM.L and BTEK.L.
Loading charts...
Drawdown Indicators
| GNOM.L | BTEK.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.32% | -38.25% | -31.07% |
Max Drawdown (1Y)Largest decline over 1 year | -18.91% | -7.81% | -11.10% |
Max Drawdown (3Y)Largest decline over 3 years | -44.77% | -26.89% | -17.88% |
Max Drawdown (5Y)Largest decline over 5 years | — | -38.25% | — |
Current DrawdownCurrent decline from peak | -37.11% | -4.00% | -33.11% |
Average DrawdownAverage peak-to-trough decline | -47.16% | -18.08% | -29.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.92% | 2.68% | +4.24% |
Volatility
GNOM.L vs. BTEK.L - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a higher volatility of 8.41% compared to iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) at 5.94%. This indicates that GNOM.L's price experiences larger fluctuations and is considered to be riskier than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM.L | BTEK.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 5.94% | +2.47% |
Volatility (6M)Calculated over the trailing 6-month period | 22.18% | 15.62% | +6.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.87% | 20.15% | +9.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.11% | 24.78% | +8.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.11% | 25.60% | +7.51% |
GNOM.L vs. BTEK.L - Expense Ratio Comparison
GNOM.L has a 0.50% expense ratio, which is higher than BTEK.L's 0.35% expense ratio.
Dividends
GNOM.L vs. BTEK.L - Dividend Comparison
Neither GNOM.L nor BTEK.L has paid dividends to shareholders.
Frequently Asked Questions
GNOM.L and BTEK.L have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEK.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEK.L is cheaper with a 0.35% expense ratio, compared with 0.50% for GNOM.L.
GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF, while BTEK.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for GNOM.L and 0.35% for BTEK.L.
Find the right allocation for GNOM.L and BTEK.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer